Skip to content
Clinical Trials – home
SpainBack to Spain

Clinical trials in Bormujos

3 clinical trials in Bormujos, Spain. Every trial is listed in the EU Clinical Trials Register and updated daily.

SpainOur site in SpainEnsayosClinicos.es(opens in a new tab)
Bormujos at a glance
3
clinical trials
  • Recruiting now0
  • Not yet recruiting0
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

3 trials in Bormujos

Open in trial search

Sepsis+1

Not recruiting
Registered drug
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Terlipressin Acetate
  • Sponsor:Fundacion Publica Andaluza Para La Gestion De La Investigacion En Salud De Sevilla
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Allogenic Corneal-Derived Adult Keratocytes, Ex-Vivo Expanded
  • Sponsor:Red Andaluza De Diseno Y Traslacion De Terapias Avanzadas Fundacion Publica Andaluza Progreso Y Salud
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Sasanlimab
  • Sponsor:Associacio Per A La Recerca Oncologica

Other cities in Spain

The busiest research cities in the country

All 218 cities in Spain

Clinical research in Bormujos

What the registry says about research in the country

01 Ophthalmology Research

Innovative research focusing on nanostructured artificial cornea development for patients with severe corneal conditions. The trials aim to provide new solutions for individuals with treatment-resistant corneal ulcers.

  • Corneal Trophic Ulcers
  • Stromal Thinning
  • Limbal Insufficiency

This groundbreaking tissue engineering approach represents a potential breakthrough for patients with limited therapeutic options.

02 Critical Care Medicine

Studies evaluating advanced treatment protocols for septic shock patients, comparing the effectiveness of different vasopressor combinations in intensive care settings.

  • Organ Failure Prevention
  • ICU Outcome Improvement
  • Vasopressor Therapy

Research focuses on reducing organ failure and improving survival rates in critical care patients.

03 Oncology Research

Clinical investigation of combination therapy for non-muscle invasive bladder cancer, specifically targeting BCG-unresponsive cases with innovative immunotherapy approaches.

  • Targeted Cancer Treatment
  • Immunotherapy Response
  • Disease Management

This phase II study explores new treatment options for patients who haven't responded to conventional therapy.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.